Miscarriage · women with endometriosis
It is very uncertain whether pentoxifylline changes miscarriage rate compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth rate · women with endometriosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain ‐ 1 month · women with endometriosis
1 finding from 1 review
Overall pain ‐ 2 months · women with endometriosis
1 finding from 1 review
All‐cause mortality · children with chronic asthma
1 finding from 1 review
Non‐fatal serious adverse events · children with chronic asthma
Children: formoterol/fluticasone showed no clear difference in all‐cause non‐fatal serious adverse events compared with salmeterol/fluticasone (low certainty).
1 finding from 1 review
Asthma‐related non‐fatal serious adverse events · children with chronic asthma
1 finding from 1 review
All‐cause mortality at last · people with liver metastases
It is very uncertain whether summary of Findings Table ‐ Electrocoagulation alone changes all‐cause mortality at last compared with control (vehicle solution of allopurinol by mouth) (very low certainty).
1 finding from 1 review
Post‐operative deaths · people with liver metastases
It is very uncertain whether summary of Findings Table ‐ Electrocoagulation alone changes post‐operative deaths compared with control (vehicle solution of allopurinol by mouth) (very low certainty).
1 finding from 1 review
Other adverse events and complications · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Tumour response · people with liver metastases
The review found no eligible studies for this question.
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis, following complete surgical excision of lesions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ pelvic pain · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ pelvic pain compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Overall Survival** · locally advanced or metastatic breast cancer
PARPi‐containing regimen showed no clear difference in overall Survival** compared with non‐PARPi regimen (high certainty).
1 finding from 1 review
Progression‐free survival · locally advanced or metastatic breast cancer
PARPi‐containing regimen leads to lower progression Free Survival** compared with non‐PARPi regimen (high certainty).
1 finding from 1 review